Pedro Gaspar: The Role of CD4⁺ T Cells in APS
Pedro Gaspar, Co-Chair at International Society on Thrombosis and Haemostasis (ISTH), Medical Doctor at North Lisbon University Hospital Centre, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Autoimmunity Reviews:
“Happy to share our latest review in Autoimmunity Reviews: ‘Dysregulation of helper, regulatory, and follicular CD4⁺ T cells in antiphospholipid syndrome.’
This article provides a comprehensive overview of current evidence supporting the role of CD4⁺ T-cell subsets – including Treg, Tfh, and Tfr cells – in the pathogenesis of antiphospholipid syndrome, highlighting emerging mechanisms and potential therapeutic targets.
A great collaborative effort.
Many thanks to all co-authors.”
Title: Dysregulation of helper, regulatory, and follicular CD4+ T cells in primary antiphospholipid syndrome: Immunopathology and implications for targeted immunomodulatory therapy
Authors: Pedro Gaspar, Filipa Ribeiro, Válter R Fonseca, Vasco C Romão, João E Fonseca, Luis Graca
Stay updated with Hemostasis Today.
-
Jun 6, 2026, 06:03Mirriam Akiru: What Does Melena Indicate?
-
Jun 6, 2026, 05:59Eugene Fan: FIBOM-AI – Predicting Marrow Fibrosis From Routine Blood Counts
-
Jun 6, 2026, 05:30Rob Maloney: The Power of Partnership in Bleeding Disorders Care
-
Jun 5, 2026, 20:51Atoosa Salimi: Why Aspirin and Other Antiplatelets Are Not Effective in Preventing Lacunar Ischaemic Stroke
-
Jun 5, 2026, 18:38Annie Bauzon: Clinical Significance and Causes of RBC Anisocytosis
-
Jun 5, 2026, 18:36Nandan Lad: Microclots as the Cause of Secondary Stroke After Subarachnoid Hemorrhage
-
Jun 5, 2026, 18:32George Sands: A Thoughtful Editorial on Low-Dose Rivaroxaban in Advanced CKD
-
Jun 5, 2026, 18:29Zain Khalpey: Recognizing High-Risk Coronary Hematoma Characteristics During PCI
-
Jun 5, 2026, 18:28Mirza Imail Baig: Silent but Significant – The Clinical Importance of Pulmonary Embolism